About
Novel Somatostatin-based Targeted Therapy Platform
Starget Pharma is focused on creating products for the diagnosis and targeted treatment of cancer through the use of targeted radiotherapy. The company develops molecules that serve as a vector for selectively transferring imaging materials and treatments directly to tumor tissue.
Identity
| Name | Starget Pharma |
|---|---|
| Slug | starget-pharma |
| Type / kind | startup |
| Crunchbase ID | starget-pharma-ltd |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkIjP2-4KDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Ramat HaSharon |
| HQ address | Ramat Hasharon, Israel |
Web & social
| Website | https://stargetpharma.com/ |
|---|---|
| https://www.linkedin.com/company/34613787 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryTest Diagnostics & Screening
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
cancer-therapypeptidespharmaceuticalsdiagnosticsbiotechnology
Funding
| Total raised | $33.1M |
|---|---|
| Current stage | Series A |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}